Loading clinical trials...
Loading clinical trials...
Phase II Trial of Perifosine in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions
Interventions
perifosine
Locations
1
United States
Duke University Medical Center
Durham, North Carolina, United States
Start Date
August 1, 2009
Primary Completion Date
October 1, 2011
Completion Date
April 1, 2013
Last Updated
May 27, 2013
NCT05006716
NCT07277231
NCT06859424
NCT01804686
NCT05254743
NCT05371808
Lead Sponsor
Daphne Friedman
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions